Schedule 13D ownership disclosure

ADDEX THERAPEUTICS LTD

Security class unavailable · CUSIP: 00654J206

Event date: 2023-11-27

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
16,863,355
Percent of class
14.1600%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-23-122019
Form type
SC 13D/A
Filer
Addex Therapeutics Ltd.
CIK
CIK 1574232
Filed
Nov 29, 2023
Reporting period
Nov 27, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub